141 related articles for article (PubMed ID: 25118484)
1. Comparison of pelvic masses score (PMS) and Risk of Malignancy Index (RMI 3) in the evaluation of pelvic masses.
Rossi A; Forzano L; Romanello I; Ambrosini G; Iuri V; Marchesoni D
Eur J Gynaecol Oncol; 2014; 35(4):421-4. PubMed ID: 25118484
[TBL] [Abstract][Full Text] [Related]
2. A proposal for a new scoring system to evaluate pelvic masses: Pelvic Masses Score (PMS).
Rossi A; Braghin C; Soldano F; Isola M; Capodicasa V; Londero AP; Forzano L; Marchesoni D
Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):84-8. PubMed ID: 21440361
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic extended usefulness of RMI: comparison of four risk of malignancy index in preoperative differentiation of borderline ovarian tumors and benign ovarian tumors.
Zhang S; Yu S; Hou W; Li X; Ning C; Wu Y; Zhang F; Jiao YF; Lee LTO; Sun L
J Ovarian Res; 2019 Sep; 12(1):87. PubMed ID: 31526390
[TBL] [Abstract][Full Text] [Related]
4. The risk of malignancy with an apparently simple adnexal cyst on ultrasound.
Obwegeser R; Deutinger J; Bernascheck G
Arch Gynecol Obstet; 1993; 253(3):117-20. PubMed ID: 8250597
[TBL] [Abstract][Full Text] [Related]
5. Comparison of risk of malignancy index (RMI), CA125, CA 19-9, ultrasound score, and menopausal status in borderline ovarian tumor.
Alanbay I; Akturk E; Coksuer H; Ercan M; Karaşahin E; Dede M; Yenen MC; Ozan H; Baser I
Gynecol Endocrinol; 2012 Jun; 28(6):478-82. PubMed ID: 22122561
[TBL] [Abstract][Full Text] [Related]
6. The risk of malignancy index (RMI) in diagnosis of ovarian malignancy.
Moolthiya W; Yuenyao P
Asian Pac J Cancer Prev; 2009; 10(5):865-8. PubMed ID: 20162854
[TBL] [Abstract][Full Text] [Related]
7. Simple descriptors and simple rules of the International Ovarian Tumor Analysis (IOTA) Group: a prospective study of combined use for the description of adnexal masses.
Peces Rama A; Llanos Llanos MC; Sánchez Ferrer ML; Alcázar Zambrano JL; Martínez Mendoza A; Nieto Díaz A
Eur J Obstet Gynecol Reprod Biol; 2015 Dec; 195():7-11. PubMed ID: 26461961
[TBL] [Abstract][Full Text] [Related]
8. [Transvaginal ultrasonography and nuclear magnetic resonance. Comparison of techniques in the evaluation of ovarian lesions].
Mascaretti G; Carta G; Renzi E; Peluzzi C; Bonitatibus A; Di Francesco CL; Patacchiola F; Moscarini M
Minerva Ginecol; 1994 Nov; 46(11):591-5. PubMed ID: 7854561
[TBL] [Abstract][Full Text] [Related]
9. Risk of malignancy index in the preoperative evaluation of pelvic masses.
Obeidat BR; Amarin ZO; Latimer JA; Crawford RA
Int J Gynaecol Obstet; 2004 Jun; 85(3):255-8. PubMed ID: 15145261
[TBL] [Abstract][Full Text] [Related]
10. Comparison of four malignancy risk indices in the preoperative evaluation of patients with pelvic masses.
Yamamoto Y; Yamada R; Oguri H; Maeda N; Fukaya T
Eur J Obstet Gynecol Reprod Biol; 2009 Jun; 144(2):163-7. PubMed ID: 19327881
[TBL] [Abstract][Full Text] [Related]
11. Risk of malignancy index used as a diagnostic tool in a tertiary centre for patients with a pelvic mass.
Håkansson F; Høgdall EV; Nedergaard L; Lundvall L; Engelholm SA; Pedersen AT; Hartwell D; Høgdall C;
Acta Obstet Gynecol Scand; 2012 Apr; 91(4):496-502. PubMed ID: 22229703
[TBL] [Abstract][Full Text] [Related]
12. Risk of malignancy index in preoperative evaluation of pelvic masses.
Ashrafgangooei T; Rezaeezadeh M
Asian Pac J Cancer Prev; 2011; 12(7):1727-30. PubMed ID: 22126553
[TBL] [Abstract][Full Text] [Related]
13. Serum C-reactive protein in the differential diagnosis of ovarian masses.
Hefler-Frischmuth K; Hefler LA; Heinze G; Paseka V; Grimm C; Tempfer CB
Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):65-8. PubMed ID: 19619929
[TBL] [Abstract][Full Text] [Related]
14. Comparison of risk of malignancy indices; RMI 1-4 in borderline ovarian tumor.
Yenen MC; Alanbay I; Aktürk E; Ercan CM; Coksuer H; Karaşahin E; Ozan H; Dede M
Eur J Gynaecol Oncol; 2012; 33(2):168-73. PubMed ID: 22611957
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis of ovarian tumors by sonography].
Wu ZY; Zhang GY; Du ZB
Zhonghua Fu Chan Ke Za Zhi; 1994 Feb; 29(2):100-2, 125. PubMed ID: 8033625
[TBL] [Abstract][Full Text] [Related]
16. Comparison of two malignancy risk indices based on serum CA125, ultrasound score and menopausal status in the diagnosis of ovarian masses.
Morgante G; la Marca A; Ditto A; De Leo V
Br J Obstet Gynaecol; 1999 Jun; 106(6):524-7. PubMed ID: 10426607
[TBL] [Abstract][Full Text] [Related]
17. Role of a risk of malignancy index in clinical approaches to adnexal masses.
Simsek HS; Tokmak A; Ozgu E; Doganay M; Danisman N; Erkaya S; Gungor T
Asian Pac J Cancer Prev; 2014; 15(18):7793-7. PubMed ID: 25292065
[TBL] [Abstract][Full Text] [Related]
18. Comparison of nine morphological scoring systems to detect ovarian malignancy.
Aktürk E; Dede M; Yenen MC; Koçyiğit YK; Ergün A
Eur J Gynaecol Oncol; 2015; 36(3):304-8. PubMed ID: 26189258
[TBL] [Abstract][Full Text] [Related]
19. [Application values of four risk of malignancy indices in the preoperative evaluation of patients with adnexal masses].
Lou HY; Meng H; Zhu QL; Zhang Q; Jiang YX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Jun; 32(3):297-302. PubMed ID: 20602883
[TBL] [Abstract][Full Text] [Related]
20. [Value of multidetector computed tomography in differentiating ovarian tumors from non-ovarian masses].
Rao SX; Zeng MS; Cheng WZ; Yang S; Miao XY; Zhang LJ; Chen G
Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):856-9. PubMed ID: 18396647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
